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Abstract: The failure of drug e cacy in clinical trials remains a big issue in cancer research. This is
largely due to the limitations of two-dimensional (2D) cell cultures, the most used tool in drug
screening. Nowadays, three-dimensional (3D) cultures, including spheroids, are acknowledged
to be a better model of the in vivo environment, but detailed cell death assays for 3D cultures
(including those for ferroptosis) are scarce. In this work, we show that a new cell death analysis
method, named 3D Cell Death Assay (3DELTA), can e ciently determine di↵erent cell death types
including ferroptosis and quantitatively assess cell death in tumour spheroids. Our method uses
Sytox dyes as a cell death marker and Triton X-100, which e ciently permeabilizes all cells in
spheroids, was used to establish 100% cell death. After optimization of Sytox concentration, Triton
X-100 concentration and timing, we showed that the 3DELTA method was able to detect signals from
all cells without the need to disaggregate spheroids. Moreover, in this work we demonstrated that
2D experiments cannot be extrapolated to 3D cultures as 3D cultures are less sensitive to cell death
induction. In conclusion, 3DELTA is a more cost-e↵ective way to identify and measure cell death
type in 3D cultures, including spheroids.
Keywords: ferroptosis; spheroids; 3D cultures; cell death assay; cancer
1. Introduction
The failure rates of new therapies during translation from preclinical research to clinical trials
remain a big issue in cancer research [1]. This is largely due to limitations of the two-dimensional (2D)
cell cultures, the most commonly used models in drug screening. The 2D cultures do not properly
resemble the structures found in vivo as they often lack cell extracellular matrix (ECM) and cell-cell
interactions, thereby influencing cell death responses to therapy (in particular to apoptosis) [2,3].
In recent years, the focus of drug screenings has shifted towards the use of three-dimensional (3D)
culture methods [4–6] as they more closely mimic the in vivo tumour microenvironment due to cell
secretion of its own ECM and the formation of cell-cell interactions [7]. Therefore, 3D structures better
resemble the structure and phenotype of the in vivo organ they are derived from [8–11]. Moreover,
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3D structures, such as spheroids, better represent in vivo drug resistance, as they form a more dense
barrier for the drugs to cross, compared to 2D systems [12], with the core of the structure being most
protected against the drugs. Therefore, with regard to the responses to therapy, including to cell death,
3D structures are better test models for drug screening compared to 2D monolayers [13].
Spheroids are one of the most widely used 3D models and can be formed by seeding cells
in nonadherent plates allowing for self-assembly (Figure 1A) [7]. In spheroids, the ECM can be
produced by cells, which acts as an extra barrier for drugs to cross in order to induce tumour cell
death [14–16]. Moreover, the compactness and stiffness of spheroids resemble the in vivohypoxic tumour
microenvironment [17], which can cause drug resistance through cell cycle arrest and downregulation
of pro-cell death proteins (e.g., caspase-3 in apoptosis) [18]. Altogether, spheroids can be more easily
formed in a high-throughput manner compared to other 3D models and better resemble in vivo
conditions, thus making them an attractive model for more efficient drug screening and analysis of cell
death responses.
 Figure 1. Principles of three-dimensional cell death assay (3DELTA). (A) Spheroids are formed by
seeding cells on top of an agarose microwell chip. This chip is made by pouring liquid agarose on
top of a polydimethylsiloxane (PDMS) mould. Cells will form clusters, leading to the formation of
spheroids. (B) Sytox Green is nonfluorescent outside of viable cells. When cells are permeabilized at
the end of the cell death process and the plasma membrane ruptures, Sytox Green will bind to the DNA
and emit green fluorescence, which can then be measured.
Of interest, in the past, cancer cell death was perceived to be dichotomic with only two ways
for a cell to die—in a regulated way (apoptosis, controlled via caspase-activation and cytochrome c
release [19]) or in an uncontrolled way (accidental necrosis) [20,21]. In line with this concept, necrosis
was seen as a form of unprogrammed cell death from cellular damage, which could be induced by
di↵erent acute physical-chemical injuries (e.g., heat shock, detergents). However, in the past few
decades, research has indicated more types of regulated cell death besides apoptosis, which are
assembled under the umbrella term ‘regulated necrosis’ [22,23]. One example of regulated necrosis
is called ferroptosis, a newly discovered pathway in cell death, which may be a potential alternative
therapeutic pathway to overcome apoptosis-resistant cancer. Ferroptosis can be induced through
blockage of Glutathione Peroxidase 4 (GPX4), an important inhibitor of ferroptotic cell death [24–26].
Of note, cell death has been thoroughly studied in 2D cultures, and despite the acceptance that 3D
cultures including spheroids are better models for the in vivo environment, not many cell death assays
exist for 3D cultures, even less for ferroptosis as the translation of the assay between culture systems is
not straightforward. Most commonly used cell death assays in 2D include Calcein AM-propidium
iodide (PI) stainings [27], immunohistochemical staining (for example Caspase-3 staining for apoptotic
cells [7]), LDH- andATP-based assays or flow cytometry for the detection ofmembrane and intracellular
markers of cell death [28–30]. However, each of these assays present their own disadvantages for
high-throughput cell death response screening in 3D cultures. For example, in Calcein AM-PI staining,
PI ions can enter viable cells with a high membrane potential which in turn leads to false positive
results [31]. For live/dead assays, such as Calcein AM-PI, the interior of the spheroids cannot be
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seen with ordinary fluorescence microscopy and require sectioning [28], a labour-extensive process.
For immunohistochemical staining, sectioning is also required, making this method cumbersome when
monitoring over time is needed [32]. ATP may be used as an indicator for cell viability, but the signal
received from ATP luminescence assays is not stable and therefore not reliable [33]. Moreover, as a
preparation step, the cells need to be lysed to extract the ATP and measure luminescence, thereby
restricting the assay to endpoint analysis. Flow cytometry is another endpoint assay that can only be
performed on single cells. Thus, spheroids must be disaggregated, a process and technique requiring
extensive training before proficient use [34].
New tools are being developed to overcome the current challenges with 3D analysis, but a simple,
quantitative method of determining real-time cell death modalities in 3D cultures remains di cult [35].
Therefore, the aim of this study is to develop a reliable assay which will allow for quantitative
determination of cell death type in spheroids. In this study, spheroids were formed by seeding tumour
cells (L929 mouse fibrosarcoma and SK-OV-3 human ovarian cancer cells) on top of nonadherent
agarose microwell chips and allowing them to self-assemble. The cell death assay was optimized using
spheroids collected on day 1. To validate the identification of cell death type, ferroptosis was induced
in spheroids collected on day 1 and 10, in the presence or absence of di↵erent cell death inhibitors
(zVAD-fmk for apoptosis, necrostatin-1s (Nec-1) for necroptosis and ferrostatin-1 (Fer-1), deferoxamin
(DFO) and ↵-tocopherol (↵-Toc) for ferroptosis). In this work we demonstrated that this method,
named the 3D Cell Death Assay (3DELTA), can e ciently and quantitatively determine di↵erent cell
death types, including ferroptosis in tumour spheroids. 3DELTA will make it possible to investigate
high-throughput cell death responses to therapy with tumour spheroids. The results from this assay
and 3D model will be more representative of therapy response in the clinic, and improve the rate of
successful drug translation into clinical trials.
2. Material and Methods
2.1. Cell Lines and Culture
L929sAhFasmouse fibrosarcomacellswere cultured inDulbecco’sModifiedEagleMedium(DMEM)
Glutamax (Life Technologies, Carlsbad, CA, USA), 10% foetal calf serum (FCS, Life Technologies) and
1% Penicillin/Streptomycin (Life Technologies) at 37  C and 5% CO2.
SK-OV-3-luc-GFP human ovarian cancer cells (kindly provided by LECR-UGent) were cultured in
DMEM Glutamax containing 10% FCS, 1% Penicillin/Streptomycin at 37  C and 5% CO2. In this study
for convenience, the L929sAhFas and SK-OV-3-luc GFP cell lines have been abbreviated to L929 and
SKOV, respectively.
2.2. Spheroid Formation
An Ultrapure Agarose solution (3% w/v, Life Technologies) was dissolved in sterile PBS and
heated. After heating, it was poured on top of a negative polydimethylsiloxane (PDMS) mould
which has a diameter of 18 mm and a height of 3 mm (NaMiFab, Ghent University, 9000 Ghent,
Belgium). Each microwell contains 2865 pores with a diameter of 200 µm and a depth of 220 µm each.
At room temperature, the solution solidified and the agarose microwell was separated from the mould.
The microwell was then placed in a 12-well culture plate. A total of 500 µL of the cell suspension,
containing 1 ⇥ 106 cells, was seeded onto the microwell, which resulted in approximately 349 cells
per pore. Either L929 or SKOV cells were used for spheroid formation and spheroids were cultured
at 37  C in a humidified 5% CO2-containing incubator. Medium was refreshed after 24 h of culture
and afterwards every two days. Either day 1 and 10 spheroids (L929) or only day 1 spheroids (SKOV)
were used.
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2.3. Sytox Dyes
Sytox dyes intercalate with DNA with a high a nity [36]. When cells are permeabilised (i.e., the
plasma membrane is ruptured) at the end of any cell death process, Sytox enters the cell and binds
to the DNA causing a large increase in fluorescence (quantum yield of 0.5, Figure 1B) which can be
measured via a fluorescence microplate reader and the Sytox signal can be correlated to the percentage
of cell death. Both Sytox Green and Sytox Blue were used for L929 and SKOVs, respectively.
2.4. Fluorescence Microscopy and Morphological Assessment of Spheroids
Induced spheroids were evaluated using an inverted fluorescence microscope (Olympus IX81).
For L929 spheroids, a GFP filter was used to visualize Sytox Green ( ex = 485 nm,  em = 520 nm) while
for SKOV-spheroids, a DAPI filter was used to visualize Sytox Blue ( ex = 444 nm,  em = 480 nm).
The geometry of spheroids was analysed using Xcellence image software (Olympus). Diameter
(d), area (A) and perimeter (p) were measured after 1, 2, 5, 7 and 10 days of culture and sphericity was





Images of 23–29 spheroids were analysed for diameter, circularity and volume.
2.5. Identification of Optimal Sytox Concentration
L929- and SKOV-spheroids were collected at day 1 and seeded in di↵erent densities (ranging from
3 to 120 spheroids per well) in a 96-well plate in duplicates. A 2D control was seeded as well in di↵erent
densities (ranging from 500 to 20,000 cells per well). Cells were stained either immediately after seeding
(spheroids) or after 24 h (2D culture) using di↵erent concentrations of Sytox Green (ranging from 1 to
5 µM) for L929-spheroids and Sytox Blue (ranging from 2.5 to 5 µM) for SKOV spheroids and after
2 h spheroids were permeabilised with 10 µL Triton X-100 (0.05% v/v, MERCK, Darmstadt, Germany).
After 2 h, Sytox intensity was measured using the Tecan Spark® (Tecan, Männedorf, Switzerland) 20M
microplate fluorescence reader (Sytox Green:  ex = 485 nm,  em = 535 nm; Sytox Blue:  ex = 430 nm,
 em = 460 nm).
2.6. Determining the Optimal Timing of Triton X-100 Treatment and Triton X-100 Concentration
L929-spheroids were collected at day 1 and seeded in di↵erent densities (30, 80 and 120 spheroids
per well) in a 96-well plate in triplicate. A 2D control was seeded as well in di↵erent densities
corresponding to the densities of cells present in the spheroids (10,620, 28,000 and 48,000 cells per
well). Cells were stained either immediately after seeding (spheroids) or after 24 h (2D culture) with
the optimal Sytox Green concentration (found in the previous experiment, Invitrogen, Carlsbad, CA,
USA) and permeabilised with di↵erent concentrations of Triton X-100 (0.05% v/v, 0.10% v/v and 0.25%
v/v) in a volume of 10 µL added to the medium. At di↵erent timepoints (each hour, starting from 2 h),
Sytox Green intensity was measured using the Tecan Spark microplate fluorescence reader.
2.7. Validation of 3DELTA: Quantification of Ferroptotic Cell Death
Spheroids were collected at day 1 and 10 (L929) and day 1 (SKOV) and seeded at a density of
80 spheroids per well in a 96-well plate in duplicate. A 2D control was seeded as well at a density
of 10,000 cells per well. Cells were stained either immediately after seeding (spheroids) or after 24 h
(2D culture) using the optimal Sytox Green (L929) or Sytox Blue (SKOV) concentration. An apoptosis
inhibitor (zVAD-fmk, BACHEM, Budendorf, Switzerland), necroptosis inhibitor (Nec-1s, Abcam,
Cambridge, UK) and multiple ferroptosis inhibitors (Fer-1, DFO and ↵-Toc, Sigma, Saint Louis, MO,
USA) were added 30 min before cell death induction with 5 µMML-162 (AOBIOUS, Gloucester, MA,
USA), an inhibitor of GPX4 and thus an inducer of ferroptosis. After 24 h, Sytox intensity was measured
using the Tecan Spark microplate fluorescence reader. Afterwards, cells were permeabilised with the
optimal Triton X-100 concentration (found in the previous experiment) to obtain 100% of cell death.
After 2 h of incubation, Sytox intensity was measured again.
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2.8. Visualization of Cell Death Pattern
Sytox fluorescence intensities were measured using the Tecan Spark® 20M microplate multimode
reader. Each well of the 96-well plate was scanned in a ‘5 ⇥ 5 filled pattern’ for a total of 21 positions per
well. A script was written in Matlab (R2018b, Mathworks, Natick, MA, USA) to extract the fluorescence
intensity data from the Tecan output file and a heat map was constructed using the pseudocolour
plot function. Shading of each pixel of the image was based on the measured fluorescent intensity at
specific positions in the well. Corners of the image have zero values as these areas were not included
in the Tecan Spark-defined scan pattern.
2.9. Statistical Analysis
The percentage of the cell death is calculated by the following formula:
averageSytox[ML162]   averageSytox[background]
average Sytox[Triton X   100]   averageSytox[background] ⇤ 100% (1)
Cell deathdata are analysedas repeatedmeasurements. Data from3 independent experimentswere
analysed. Statistical analysis is performed using GraphPad Prism 8.0 software and are represented by
mean± SEM.Data are analysedwith two-wayANOVA. p-values less than 0.05 are considered significant.
3. Results
3.1. Linear Correlation between Sytox Intensity and Cell Density
First, the L929 and SKOVspheroid geometrywas characterized over time (Figure 2A). The diameter,
sphericity and volume were measured and calculated for day 1, 2, 5, 7 and 10. L929 diameter increased
from an average diameter of 150 ± 1.30 µm on day 1 to 180.83 ± 1.03 µm on day 10 and SKOV diameter
increased from 130 ± 1.63 µm on day 1 to 148.44 ± 2.81 µm on day 10. Sphericity remained stable
around 90% and 75% for L929 and SKOV spheroids, respectively. The volume increase over time of
spheroids correlates with an initial compaction phase followed by the proliferative phase of cancerous
cells [37].
In order to correctly extrapolate the percentage of cell death over time, a linear correlation between
the cell number and Sytox intensity is required. Therefore, the optimal Sytox concentration was
established by testing a range of concentrations from 1 to 5 µM for Sytox Green and from 2.5 to 5 µM
for Sytox Blue. Of note, Sytox Blue has a lower signal-to-noise ratio than Sytox Green [38]. For 2D
cultures, the optimal concentration were already determined as 3.3 µM for Sytox Green in a previous
study [39] and 5 µM for Sytox Blue, which was also confirmed in this study (supplemental Figure S1A,E).
For L929 spheroids (Figure 2B) the same concentration can be applied for Sytox Green, based on the
linear correlation (R2 = 0.9902, Figure 2C). In the case of SKOV spheroids (Figure 2E), it was observed
that 4 µM of Sytox Blue had the highest linear correlation with cell density (R2 = 0.9156, Figure 2F).
These optimal concentrations were then used for all further experiments. An optimal spheroid density
was determined from a range of 30 to 120 spheroids per well (Figure 2D,G). Of note, we measured
a large increase of fluorescence when the number of spheroids per well was above 30. Thus, in the
following experiments, spheroids were seeded at a density of 80 spheroids per well.
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Figure 2. Characterization of the spheroids and analysis of linear correlation between Sytox intensity
and cell density. (A) Diameter, sphericity and volume of L929 and SKOV spheroids. (B) Brightfield
image of day 1 L929 spheroids showing globular spheroids that are not yet fully compacted. (C) Sytox
Green intensity for di↵erent concentrations of Sytox Green was plotted out against di↵erent spheroid
densities. Linear correlation was measured as R2 and the highest correlation was found for Sytox
Green 3.3 µM. (D) The increase of Sytox intensity for Sytox Green 3.3 µM is shown. Starting from 30
spheroids, a high increase in intensity was found until 120 spheroids. (E) Brightfield image of day 1
SKOV spheroids showing irregularly shaped spheroids that are quite compact. (F) Sytox Blue intensity
for di↵erent concentrations of Sytox Blue was plotted out against di↵erent spheroid densities. Linear
correlation was measured as R2 and the highest correlation was found for Sytox Blue 4 µM. (G) The
increase of Sytox intensity for Sytox Blue 4 µM is shown. Starting from 30 spheroids, a high increase in
intensity was found until 120 spheroids.
3.2. Sytox Signal Penetrates All Cells in the Spheroids
In order to obtain the maximal intensity of the Sytox dyes, which corresponds to 100% cell
membrane permeabilization and cell death, Triton X-100 was used to physically rupture the membrane.
Previously in 2D cultures, TritonX-100was used at a concentration of 0.05% (v/v) in order to permeabilize
the cells and establish 100% cell death (39). However, spheroids maintain a structure of higher
complexity than 2D cultures (Figures 1B and 2B,E). Therefore, optimization of spheroid permeabilization
was performed. After staining with Sytox, spheroids were permeabilised using di↵erent concentrations
of Triton X-100 (0.05%, 0.10% and 0.25%). To ensure that all cells undergo permeabilization after
addition of Triton X-100, spheroids were disaggregated with trypsin. The fluorescence intensity of this
2D suspension was then compared to that of untrypsinized 3D spheroids.
Since the optimal gain setting is an inherent characteristic of fluorescence readers, we tested this
first for our machine. The optimal gain setting was established by determining the gain with the highest
linear correlation between Sytox Green intensity and cell density (Figure 3A). The highest correlation
was found at gain 45 and 50 (R2 = 1.000) and a gain 45 was used for the subsequent experiments.
Next, top and bottom measurements were compared for spheroids (Figure 3B), which revealed that a
more intense signal was received with less variation from top measurement, meaning that this setting
was optimal for spheroid cultures. Furthermore, the incubation time with Triton X-100 required to
permeabilize spheroids was tested and compared to 2D cultures (Figure 3C). Since the intensity of
the Sytox signal did not change over time, this indicated that two hours was enough time to fully
permeabilize spheroids with Triton X-100 at all concentrations.
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Figure 3. Triton X-100 e ciently permeabilizes spheroids. L929 spheroids were stained with 3.3 µM
of Sytox Green and permeabilised with Triton X-100 in di↵erent concentrations (0.05%, 0.10% and
0.25%). Sytox Green intensity was measured using the Tecan Spark microplate reader. Either top or
bottom measurement was used, and intensity was measured at di↵erent timepoints. (A) Optimal
gain setting. The highest linearity is found at gain 45 and 50. (B) Comparison of top and bottom
measurement. The most intense signal of Sytox Green with the lowest variation is found in top
measurement. (C) Optimal timing for measurement. No di↵erences were observed at the di↵erent
timepoints. (D–F) Comparison of normal and trypsinized spheroids at di↵erent cell densities and
with di↵erent Triton X-100 concentration. No significant di↵erences in Sytox Green intensity were
observed between normal and trypsinized. Furthermore, no significant di↵erences were found between
di↵erent Triton X-100 concentrations. Data are averages from three independent experiments (n = 3),
each measured in triplicate; error bars = SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
RFU = relative fluorescent unit.
The comparison between standard and trypsinized spheroids was made for 30, 80 and 120
spheroids seeded per well; using di↵erent concentrations of Triton X-100: 0.05%, 0.10% or 0.25%
(Figure 3D–F). No significant di↵erences were found between di↵erent Triton X-100 concentrations and
therefore, Triton X-100 0.05% (v/v) was used to permeabilize spheroids in all subsequent experiments.
Importantly, no significant di↵erences were observed between Sytox green intensity in standard
spheroids and trypsinized spheroids (p > 0.05, n = 3). This indicates both that the cell death stain can
penetrate into the core of intact spheroids and that the fluorescence emission can be detected.
3.3. Validation of 3DELTA: Quantification of Ferroptotic Cell Death
In order to validate cell death identification and quantification at the optimized measurement
conditions for spheroids, ferroptotic cell death was induced with 5 µMML-162, an inhibitor of GPX-4,
and the 3DELTA method was performed. Di↵erent inhibitors of cell death modalities were added
to confirm the type of cell death in spheroids—apoptosis (zVAD-fmk), necroptosis (Nec-1) and for
ferroptosis (Fer-1, DFO and ↵-Toc) [40]. Visualization of cell death was performed for each well based
on measured fluorescence intensities. A predefined scan pattern was used to measure Sytox intensity
at specific points in the well, and a Matlab script was used to compile the data and construct heat maps.
Based on the heat maps, the inhibitory e↵ect of Fer-1, DFO and ↵-Toc and the distribution of cell death
in each well are apparent (Figure 4A). Furthermore, it is clear that cell death induction is more e cient
in day 1 spheroids compared to day 10 spheroids as well as inhibition of cell death.
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of inhibitors towards the centre of the spheroids. 
 
Figure 4. Validation of 3DELTA—quantification of ferroptotic cell death in spheroids. Ferroptosis
was induced using 5 µM ML-162. Spheroids were stained with Sytox Green (L929) or Sytox Blue
(SKOV) and cell death was measured after 24 hours as increase in fluorescence intensity using Tecan
Spark microplate reader. Afterwards, spheroids were permeabilised with Triton X-100 0.05% (v/v).
Fluorescence intensity was measured and used as 100% cell death. (A) Sytox was measured in a
consistent, predefined pattern (21 positions per well), and heat maps of the entire well were generated
in Matlab based on fluorescence intensities. Optimal gains were used for each cell line (gain 45, D1
L929; gain 45, D10 L929; gain 55, D1 SKOV). The corners shown here are zero values as these areas were
not measured in the predefined Tecan Spark scan pattern. Experiments were performed in triplicate
and representative images are shown here. (B) Fluorescence pictures of day 1 and 10 L929 spheroids.
Control spheroids show cell death in their core which might be due to hypoxia leading to a necrotic
core. Representative images are shown here. Scale bar = 200 µm (C) Quantification of cell death in
normal and trypsinized spheroids. Data are averages from three independent experiments (n = 3),
each measured in triplicate; error bars = SEM. * p < 0.05, ** p < 0.01, *** p < 0.001, ns = not significant.
The first line represents the comparison between standard and trypsinized spheroids and the second
line represents the comparison between control spheroids and spheroids induced with ML-162 and
between induced spheroids and spheroids where inhibitors were added. (D) Brightfield image of
control (upper panel) and induced (lower panel) L929 cells. All cells are stained with Sytox Green.
(E) Quantification of cell death in L929 (upper panel) and SKOV (lower panel) 2D culture.
Interestingly, both day 1 and 10 spheroids showed cell death in the core in control spheroids
(Figure 4B) which could be due to hypoxia leading to a necrotic core [17]. ML-162 induced a significant
increase of cell death to around 50% compared to control L929 spheroids that were collected at day 1
(Figure 4A,C). However, the cell death response was decreased to around 30% in day 10 spheroids.
The decrease in ferroptosis could be caused by an increase in complexity of spheroids over time and
secretion of extracellular matrix [16]. For day 1 SKOV spheroids, approximately 85% of cell death was
observed after stimulation with ML-162. The addition of ferroptosis inhibitors (i.e., Fer-1, DFO and
↵-Toc) to drug-induced spheroids significantly reduced cell death, indicating that the induced cell death
followed the ferroptosis pathway. However, this was less prominent with DFO, compared to Fer-1 and
↵-Toc. The addition of zVAD-fmk, which inhibits apoptosis, appears to increase the amount of cell
death and may be due to the induction of necroptosis via inhibition of caspase-8 [41]. It has previously
been shown that zVAD-fmk can induce necroptosis via induction of tumour necrosis factor-↵ (TNF↵)
through the mitogen-activated kinases (MAPKs) pathway [42]. In day 10 L929 spheroids, inhibition of
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ferroptotic cell death was also less pronounced, which may be due to the more complex nature at day
10, preventing e cient di↵usion of inhibitors towards the centre of the spheroids.
A comparison between normal and trypsinized spheroids was also made with the inhibitors
(Figure 4C). Importantly, significant di↵erences were found between the two conditions.
These di↵erences might be explained by the stress induced by the trypsinization procedure, which leads
to dysregulated cell functions [43]. This was particularly apparent in day 10 spheroids where the cells
were treated with collagenase-1 for 30 min. Collagenase-1 was used to disaggregate day 10 spheroids
as trypsin could not e ciently degrade the ECM produced in this more advanced stage. Already in
the control group, more cell death was observed, and here, the di↵erences between trypsinized and
nontrypsinized spheroids were even more pronounced. It also means that using trypsinized spheroids
might give a wrong representation of cell death induction and lead to false positive or negative results.
However, in day 1 SKOV spheroids, no significant di↵erences between standard and trypsinized
spheroids was found. In contrast, there was a large variation in the percentage of permeabilised cells
in trypsinized SKOV spheroids, which may also contribute to false results in this case.
4. Discussion
High failure rates in drug development when entering into the clinic is a large healthcare problem.
A major contributing factor is due to the poor models used in early target development which are
mainly in 2D models. In this work, cell death was induced in spheroids which are more representative
of the in vivo environment. We show that a new cell death analysis method (i.e., 3DELTA) can
e ciently determine di↵erent cell death types including ferroptosis and quantitatively assess cell death
in tumour spheroids. These results obtained from 3D cultures might be more relevant to the clinic and
consequently will save time, money, and resources for drug development.
This work also strongly highlights the advantage of the 3DELTA method over existing cell death
measurements [44], which require disaggregation of spheroids at one specific timepoint for analysis. Not
only is the disaggregation process time-consuming, it also cannot be applied for kinetic measurements
as it destroys the 3D environment. With the 3DELTA method, real-time kinetic and high-throughput
measurements are possible if the machine is coupled to a CO2 inlet and a heating control. Moreover, in
this work it was shown that 2D experiments cannot be extrapolated towards 3D cultures as 3D cultures
are less sensitive to cell death induction. In 2D cultures, ferroptosis induction leads to approximately
90% cell death (Figure 4E) while in day 1 spheroids this was already reduced to 50% and even to 30% in
day 10 spheroids. Due to tumour heterogeneity, the responses between di↵erent tumour types might
di↵er because of di↵erent sensitivity to cell death induction, which was also represented in this work as
the SKOV cell line seemed to be more sensitive to ferroptosis [45]. These two cell lines have been chosen
because they are extensively used in cell death research in 2D cultures [42,46,47]. Furthermore, use of
two di↵erent cancer cell lines (murine fibrosarcoma and human ovarian cancer cell line) circumvents
a lot of risks with cell type specificity of the DELTA assay. These data suggest that this method is
also applicable to other cell lines. The application of 3D cultures is more representative to the in vivo
situation as spheroids better resemble in vivo tumours. Moreover, ferroptosis will be an alternative
strategy in cancer therapy, especially in apoptosis- and necroptosis-resistant cases [23,48]. Ferroptosis
is induced via blockade of the system xc cysteine/glutamate antiporter or glutathione peroxidase 4
(GPX4), resulting in a defective GSH-redox system where oxidized phosphatidylethanolamines are
crucial for ferroptosis execution [26,49]. In the proposed 3DELTA method, it is possible to monitor
ferroptotic cell death in time kinetics and without disaggregation of the spheroids. We were able
to induce ferroptosis in 3D cancer models allowing the possibility of ferroptosis to be exploited in
the future therapies. Of course, there are other important pathways which can contribute to cell
death, such as autophagy. Autophagy often precedes cell death (e.g., apoptosis or ferroptosis) after
which the cells will become Sytox positive [50,51]. Indeed, we have only used inhibitors for apoptosis,
necroptosis and ferroptosis. However, this method can be easily adapted to include other inhibitors
like autophagy inhibitors.
Cells 2020, 9, 703 10 of 13
3DELTA proved to be a simple and e cient cell death assay to identify and quantify cell death
modality in 3D cultures (i.e., spheroids) compared to the current state-of-the-art methods. It does not
require the disaggregation of spheroids, making it less labour-extensive and allowing for potential
real-time kinetic experiments. 3DELTA can be easily adapted to di↵erent stimuli and/or inhibitors.
This is highly advantageous for high-throughput drug screenings in 96- and 384-well plates. However,
several factors, summarized in Table 1, should be taken into consideration for the proper use of this
assay. In summary, we have developed a more cost-e↵ective way to measure cell death and determine
its type in 3D cultures including spheroids.
Table 1. Troubleshooting.
Issue Solution
Higher Sytox intensity in stimulated cells than with
Triton X-100 leading to cell death higher than 100%
Resuspend more vigorously and repeat after 1 h
Increase Triton X-100 concentration
Trypsinization incomplete for D10 spheroids Include an incubation step with collagenase I insteadof using trypsin
Spheroids disaggregate after 1 day during ferroptosis
assay when using adherent plates
Use suspension plate instead of adherent plates to
avoid cells adhering to plate
Intensity too high: overestimated Use lower gainsOptimize gain settings for new cell lines
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